1 We previously reported that acute incubation with tetrahydrobiopterin (BH 4 ) or sepiapterin, a cofactor for endothelial nitric oxide synthase and a stable precursor of BH 4 , respectively, enhanced the acetylcholine (Ach)-induced relaxation of isolated small mesenteric arteries (SMA) from diabetic (db/ db) mice. In this study, we investigated the effect of chronic oral supplementation of sepiapterin (10 mg kg À1 day
Introduction
) is an essential cofactor required for the biosynthesis of nitric oxide (NO) by nitric oxide synthase (NOS). Although the exact mechanism whereby BH 4 regulates NOS activity is not known, several different hypotheses have been proposed viz., BH 4 exerts an allosteric action to stabilize the active dimeric state of NOS, it plays a redox active role in stimulating NOS, it increases the binding of L-arginine to NOS and scavenges reactive free radicals or it plays a role in the electron transfer to the ferrousdioxy intermediate by forming a pterin radical, thus enabling the formation of a heme-based oxidant that rapidly hydroxylates L-arginine (Klatt et al., 1994; Kojima et al., 1995; Mayer & Werner, 1995; Hurshman et al., 1999; Wei et al., 2001) .
In situations where there are suboptimal concentrations of BH 4 , endothelial NOS (eNOS) will generate superoxide in addition to NO. For instance, biochemical studies with purified constitutive NOS have demonstrated that in the presence of suboptimal concentrations of BH 4 , there is an uncoupling of NOS and subsequent formation of superoxide and hydrogen peroxide (Pou et al., 1992; Wever et al., 1997; Vasquez-Vivar & Kalyanaraman, 2000) . Blockade of BH 4 synthesis with 2,4-diamino-6-hydroxypyrimidine (DAHP), a selective guanosine triphosphate (GTP) cyclohydrolase I inhibitor, results in impaired endothelial function in isolated aorta, coronary, mesenteric and cerebral arteries (Cosentino & Katusic, 1995; Kinoshita et al., 1997; Tiefenbacher et al., 2000; Pannirselvam et al., 2002) . Compared to control values, levels of BH 4 have been shown to be decreased in aorta from insulin-resistant rats, in coronary endothelial cells from biobreeding (BB) diabetic rats and in aorta from spontaneously hypertensive (SHR) rats (Shinozaki et al., 1999; Meininger et al., 2000; Hong et al., 2001) . Thus, supplementation with BH 4 would be expected to restore impaired endothelium function and improve cardiovascular function in diabetes and other cardiovascular pathological conditions. BH 4 has been shown to improve endothelium-dependent vasorelaxation in isolated aorta from streptozotocin-induced diabetic rat, fructose-fed insulin-resistant rats and coronary arteries following reperfusion injury (Tiefenbacher et al., 1996; Pieper, 1997; Shinozaki et al., 1999) . BH 4 has also been shown to improve relaxation in blood vessels from patients with coronary artery disease, type II diabetes, smokers and atherosclerosis (Heitzer et al., 2000; Maier et al., 2000; Tiefenbacher et al., 2000; Heitzer et al., 2001) . Chronic treatment with BH 4 has been shown to improve endothelial dysfunction in aorta from fructose-fed insulin-resistant rats and decrease the elevated blood pressure in SHR rats (Shinozaki et al., 2000; Hong et al., 2001) . We have reported endothelial dysfunction in isolated small mesenteric arteries (SMA) from diabetic (db/ db) mice and also shown that acute incubation with BH 4 , sepiapterin or with a combination of polyethylene glycol superoxide dismutase (PEG-SOD) and catalase significantly improved acetylcholine (Ach)-induced relaxation (Pannirselvam et al., 2002) . The objective of the present study was to investigate the effects of the chronic oral supplementation of sepiapterin on endothelial function, biopterin contents and lipid peroxidation in SMA from diabetic (db/db) mice.
Methods

Animals
Male C57BL/KsJ diabetic mice (db/db) and nondiabetic controls (db/ þ ), 6-week-old, were purchased from The Jackson Laboratory (Bar Harbour, ME, U.S.A.). At 8 weeks of age, animals were divided into four groups -group 1: db/ þ mice receiving powder chow for 8 weeks, group 2: db/ þ mice receiving sepiapterin (10 mg kg À1 day
À1
) in powder chow for 8 weeks, group 3: db/db mice receiving powder chow for 8 weeks and group 4: db/db mice receiving sepiapterin (10 mg kg À1 day
) in powder chow for 8 weeks. In accordance with a protocol approved by the University of Calgary animal care committee, mice were killed by cervical dislocation. Heparinized blood samples were collected for blood biochemistry. The mesenteric arcade was removed and first-order branches of the mesenteric artery (measuring approximately 150 -200 mm in diameter) were dissected in cold Kreb's solution of the following composition (in mM): NaCl 120, NaHCO 3 25, KCl 4.8, NaH 2 PO 4 1.2, MgSO 4 1.2, dextrose 11.0, CaCl 2 1.8, aerated with 95% O 2 and 5% CO 2 . The rest of the arterial bed was immediately stored at À701C for biochemical measurements.
Wire myograph studies
Isometric tension studies using wire myograph were performed as described previously (Pannirselvam et al., 2002) . SMA were cut into 2 mm ring and mounted on a Mulvany -Halpern myograph. The passive tension-internal circumference was determined by stretching to achieve an internal circumference equivalent to 90% of that of the blood vessel under a transmural pressure of 100 mmHg. All the experiments were performed at 371C. Concentration -response curves to phenylephrine (PE) were constructed and normalized relative to the contraction induced by 120 mM KCl. Subsequently, endothelium-dependent and independent relaxations to Ach and sodium nitroprusside (SNP), respectively, were studied in tissues precontracted with a submaximal concentration of PE.
Determination of GTP cyclohydrolase I activity and biopterin content in SMA GTP cyclohydrolase I activity in SMA was measured as previously described (Vann et al., 2000) . Homogenized SMA was incubated with Tris-HCl buffer (pH 7.4), 10 mM dithiothreitol, 10 mg ml À1 bovine serum albumin, 10 mM GTP for 2 h at 371C. The reactions were terminated with 1 M HCl and oxidized with iodine reagent (1% I 2 /2% KI, 1 : 1, wv
À1
). Neopterin triphosphate was dephosphorylated by incubating with 10 U of alkaline phosphatase for 30 min at 371C. the reactions were terminated by adding 1 M phosphoric acid. Samples were centrifuged and the amount of neopterin formed was measured by reverse-phase high-performance liquid chromatography with fluorometric detection as described earlier. Neopterin levels were normalized to the amount (mg) of protein.
The biopterin contents of the SMA were measured by reverse-phase high-performance liquid chromatography as described previously (Howells et al., 1986) . SMA were homogenized in 25 mM triethanolamine-HCl (pH 7.4) containing 1 mg ml À1 dithioerythritol and diethylenetriaminepentacetic acid and separated using ultrafree-MC tubes (Millipore Co., U.S.A.) by centrifuging at 5000 r.p.m. for 15 min at 41C. The filtrates were immediately used for BH 4 and biopterin assays. BH 4 was measured directly using an ESA Coulochem electrochemical detector, dihydrobiopterin (BH 2 ) was measured by fluorescence (358/447 nm) after oxidation on the conditioning cell electrode and biopterin was measured by its natural fluorescence (358/447 nm). BH 4 and biopterin measured were normalized relative to the amount (mg) of protein.
Determination of lipid peroxidation in plasma and SMA
Thiobarbituric acid reactive substance, malondialdehyde, a marker for lipid peroxidation, was measured in plasma and SMA, using a commercial kit (OXI-TEK, ZeptoMetrix Co. U.S.A.) according to the manufacturer's instructions. The levels of malondialdehyde were normalized to milligrams of protein.
Protein assay
Protein content was determined by the method of bicinchoninic acid using a commercial kit from Pierce Co., U.S.A.
Drugs
L-Sepiapterin, a precursor of BH 4 , was obtained from Schircks Laboratories (Switzerland). All other chemicals were purchased from Sigma Chemicals (St Louis, MO, U.S.A.).
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Biochemical measurement of plasma glucose, triglyceride and cholesterol were performed using commercial kit from Sigma Diagnostics (St Louis, MO, U.S.A.).
Statistics
All values are expressed as mean7s.e.m.. The relaxation is expressed as mean percentage (7s.e.m.). In all experiments, n equals the number of animals used in the protocol. The concentration -response curves among the four groups were compared using a repeated measures ANOVA test. Statistical significance of difference in biochemical parameters among four groups was performed using one-way ANOVA. Multiple comparisons of the paired groups were performed using Student -Newman -Keuls method. A P-value of less than 0.05 was considered statistically significant.
Results
Metabolic characteristics in db/db mice
The db/db mice showed higher body weight compared to db/ þ mice. Oral treatment with sepiapterin had no effect on body weight in either db/db or db/ þ mice ( Table 1 ). The db/db mice showed elevated levels of plasma glucose, cholesterol and triglyceride compared to db/ þ mice. However, sepiapterin treatment had no effect on the biochemical parameters in either db/ þ or db/db mice ( Table 1) .
Effect of sepiapterin treatment on vascular reactivity
The PE-induced maximum contraction was significantly higher in SMA from db/db mice compared to db/ þ mice. Treatment with sepiapterin significantly reduced the maximum contraction of SMA to PE in db/db mice, but not in SMA from db/ þ mice (Figure 1 ). PE-induced maximum contractions were 12474, 12579, 15074 and 13476 (% 120 mM KCl) for db/ þ , db/ þ treated with sepiapterin, db/db and db/ db treated with sepiapterin, respectively. Ach induced a concentration-dependent relaxation of SMA from db/ þ and db/db mice; however, maximum relaxations were significantly reduced in SMA from db/db mice compared to db/ þ mice. Sepiapterin treatment significantly improved the relaxation to Ach in SMA from db/db mice but not in SMA from db/ þ mice (Figure 2 ). Sensitivity (expressed as pD 2 ) and maximum relaxation (expressed as %) to Ach were 7.570.1 and 9572, 7.370.1 and 9671, 6.470.1 and 6676 and 7.270.2 and 7772 for db/ þ , db/ þ treated with sepiapterin, db/db and db/db treated with sepiapterin, respectively. SNP induced a concentration-dependent relaxation of SMA from db/ þ and db/db mice, which were comparable and not altered in sepiapterin-treated groups (Figure 3 ). Sensitivity (expressed as pD 2 ) and maximum relaxation (expressed as %) to SNP were 8.170.2 and 9871, 8.070.1 and 9571, 7.670.1 and 9670.5 and 8.070.1 and 9571 for db/ þ , db/ þ treated with sepiapterin, db/db and db/ db treated with sepiapterin, respectively.
Effect of sepiapterin treatment on GTP cyclohydrolase I activity and biopterin contents
The level of neopterin, as a measure of GTP cyclohydrolase I activity, was not significantly different in SMA from db/ þ and db/db mice. Sepiapterin treatment had no effect on GTP cyclohydrolase I activity in SMA from either db/ þ or db/db mice (Figure 4) .
The level of BH 4 in SMA was not significantly different between db/ þ and db/db mice ( Figure 5 ). Sepiapterin treatment had no effect on BH 4 levels in SMA from either db/ þ or db/db ( Figure 5 ). The BH 2 þ biopterin content in mesenteric arteries was significantly higher in db/db mice compared to db/ þ mice ( Figure 6 ). Sepiapterin treatment reduced the content of BH 2 þ biopterin in SMA from db/db mice to control values ( Figure 6 ). When the biopterin contents were expressed as a ratio of BH 4 to BH 2 þ biopterin, the value was significantly lower in SMA from db/db mice compared to db/ þ mice. Sepiapterin treatment had no effect on the ratio of BH 4 to BH 2 /biopterin in either db/db or db/ þ mice (Figure 7) .
Effect of sepiapterin treatment on lipid peroxidation levels in plasma and SMA
Malondialdehyde, a marker for lipid peroxidation, was significantly elevated in plasma and SMA from db/db mice compared to db/ þ mice (Figure 8a and b) . Sepiapterin treatment had no effect on malondialdehyde levels in plasma from db/db and db/ þ mice (Figure 8a ). Sepiapterin treatment significantly reduced the elevated levels of malondialdehyde in SMA from db/db mice, but not in db/ þ mice (Figure 8b ).
Discussion
Chronic oral supplementation of sepiapterin prevented the enhanced vascular contractility to PE and improved relaxation to Ach in SMA from db/db mice. Sepiapterin treatment lowered the levels of BH 2 þ biopterin and malondialdehyde in SMA from db/db mice, but did not affect the levels of either BH 4 or GTP cyclohydrolase activity. These results suggest that increased oxidative stress and oxidized products of BH 4 (BH 2 þ biopterin) contribute to endothelial dysfunction in SMA from db/db mice. Sepiapterin treatment restores 
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endothelial function in SMA from db/db mice by decreasing the levels of lipid peroxidation and BH 2 þ biopterin contents. We previously reported improved relaxation to Ach following acute treatment with BH 4 or sepiapterin in SMA from db/db mice (Pannirselvam et al., 2002) . In the current study, we showed that chronic oral supplementation with sepiapterin improved endothelium-dependent relaxation of SMA to Ach and reduced vascular reactivity to PE. Treatment with sepiapterin, however, did not alter SNP-induced endothelium-independent relaxation. These findings are in agreement with previous reports in fructose-fed insulin-resistant rats and spontaneously hypertensive rats (Shinozaki et al., 2000; Hong et al., 2001) . These data also support the hypothesis that a decreased bioavailability of BH 4 , either due to a decreased synthesis or increased oxidation of BH 4 , contributes to endothelial dysfunction in SMA from db/db mice. BH 4 is synthesized by two pathways. The de novo synthesis pathway that uses GTP as a precursor where GTP cyclohydrolase I is the rate-limiting enzyme, and by a salvage pathway Figure 1 Effect of oral supplementation of sepiapterin on vascular reactivity to PE of SMA from db/ þ and db/db mice. The PEinduced contraction was normalized to 120 mM KCl. The data are expressed as mean7s.e.m. based on seven to eight experiments. *Po0.05 compared to db/ þ and db/ þ treated with sepiapterin group. Effect of oral supplementation with sepiapterin on BH 2 þ biopterin levels in SMA from db/ þ and db/db mice. The values are mean7s.e.m. pmol mg À1 of protein based on five to six experiments. *Po0.05 compared to db/ þ and db/ þ treated with sepiapterin group.
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Sepiapterin on endothelial dysfunction in diabetes where BH 4 is regenerated from quinonoid form of the BH 2 using dihydropteridine reductase (DHPR, Mayer & Werner, 1995) . GTP cyclohydrolase I and DHPR activity were reduced in aorta from the fructose-fed insulin-resistant rat model and exhibited endothelial dysfunction with decreased levels of BH 4 , decreased production of NO and an increased production of superoxide anion (Shinozaki et al., 2000) . Similar results were reported in coronary artery endothelial cells from BB diabetic rats (Meininger et al., 2000) . However, in the current study, we did not observe any change in the BH 4 level or GTP cyclohydrolase I activity in SMA from db/db mice. These data indicate that an impaired biosynthetic pathway for BH 4 is not the cellular basis for endothelial dysfunction in the db/db mouse model. The level of BH 2 þ biopterin was elevated in SMA from db/db mice, thus decreasing the ratio of BH 4 to BH 2 and biopterin. Increased oxidation of BH 4 to BH 2 and biopterin would result in decreased levels of BH 4 . Surprisingly, we did not observe a change in the BH 4 levels in SMA from db/db mice. Based on the recent report, we speculate that BH 4 is oxidized to trihydrobiopterin (BH 3 *) radical as well as BH 2 and biopterin (Kuzkaya et al., 2003) . BH 3 * radical is converted back to BH 4 by ascorbate, maintaining levels of BH 4 , whereas BH 2 and biopterin accumulates in the system probably because BH 2 cannot be converted to BH 4 due to decreased expression or activity of DHPR. Vasquez-Vivar et al. (2002b) reported that the relative proportion of the oxidized to the reduced BH 4 metabolites regulate eNOS activity and the generation of superoxide. Thus, in the present study, increased levels of BH 2 þ biopterin may competitively antagonize the binding of BH 4 to eNOS and thus uncouple eNOS. However, further experiments are required to investigate this hypothesis. Increased oxidization of BH 4 in SMA from diabetic mice may result from an increased reactive oxygen species (ROS) and oxidative stress (Giugliano et al., 1996) . ROS may impair endothelium-dependent relaxation by rapidly inactivating NO resulting in the formation of peroxynitrite. BH 4 is a powerful reducing agent and it is possible that excess peroxynitrite formation may lead to oxidation and depletion of BH 4 (Milstien & Katusic, 1999) . In the present study, malondialdehyde levels were elevated in plasma and SMA from db/db mice and were restored to within the control range by sepiapterin treatment, suggesting that the restoration of the endothelial function by sepiapterin could in part be explained by an antioxidant action of sepiapterin. Direct antioxidant properties of BH 4 have also been documented by Kojima et al. in xanthine/xanthine oxidase free-radical generating system and phorbol myristate acetate stimulated rat macrophage generated free radicals (Kojima et al., 1995) . Oral supplementation with BH 4 normalized vascular superoxide production, membrane lipid peroxidation and prevented the activation of nuclear factor kappa B, activating protein-1 in insulin-resistant rats (Shinozaki et al., 2000) . Patel et al. (2002) reported that the scavenging efficiency of BH 4 was comparable to ascorbate and could be a biologically viable antioxidant (Patel et al., 2002) . This will also explain the effect of sepiapterin treatment on enhanced vascular reactivity to PE in SMA from db/db mice. Free radicals are known to impair endothelium integrity, enhance alpha-adrenergic receptor-mediated turnover of phosphoinositol and augment contractility through calcium channels (Chang et al., 1993) . Paradoxical negative reports, however, have been reported on the effects of sepiapterin on endothelial dysfunction. Sepiapterin attenuated Ach-and A23187-induced relaxation of isolated aorta from cholesterol-fed rabbits although increased the levels of BH 4 (VasquezVivar et al., 2002a) . It is possible that prolonged exposure to high concentration of sepiapterin has a direct effect to uncoupled eNOS, resulting in the production of superoxide instead of NO.
In conclusion, increased oxidative stress through oxidation of BH 4 uncouples eNOS leading to endothelial dysfunction in SMA from db/db mice, and oral treatment with sepiapterin improves endothelial dysfunction by reducing oxidative stress.
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